Drug profile · INN
hyaluronidase recombinant human
HYLENEX RECOMBINANT
hyaluronidase recombinant human (HYLENEX RECOMBINANT) is a hyaluronic acid hydrolytic enzyme. Associated with HALOZYME THERAPEUTICS, INC.. Route of administration: injection. Current US regulatory status: approved.
Drug details — hyaluronidase recombinant human
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 16
- Programs
- 4
- Data quality
- 0.89
Quick answer
hyaluronidase recombinant human (HYLENEX RECOMBINANT) is a hyaluronic acid hydrolytic enzyme. Associated with HALOZYME THERAPEUTICS, INC.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Hyaluronic acid hydrolytic enzyme
Primary target: Hyaluronic acid
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12371685
PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof
granted -
US 12077791
PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof
granted -
US 10588983
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 10016491
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 9683985
Methods for assessing and identifying or evolving conditionally active therapeutic proteins
granted -
US 9211315
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 8927249
Extended soluble PH20 polypeptides and uses thereof
granted -
US 8815558
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
granted -
US 8580252
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 8257699
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 8105586
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 7871607
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 7846431
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 7829081
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 7718428
Myeloid colony stimulating factor and uses thereof
granted -
US 7544499
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
granted
Frequently asked questions
What is hyaluronidase recombinant human?
hyaluronidase recombinant human (HYLENEX RECOMBINANT) is a hyaluronic acid hydrolytic enzyme. Associated with HALOZYME THERAPEUTICS, INC.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for hyaluronidase recombinant human?
HYLENEX RECOMBINANT is a marketed brand name for hyaluronidase recombinant human. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hyaluronidase recombinant human?
hyaluronidase recombinant human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.